Fundamental Frequency of the Voice in Schizophrenia and Its Value as a Biomarker of the Disease
Recent research on schizophrenia seeks to identify objective biomarkers of the disease. The voice, and in particular the fundamental frequency (F0), could be one of them. We conducted a cross-sectional and descriptive study with a sample of 154 people. Of these, 46 were diagnosed with schizophrenia,...
Gespeichert in:
Veröffentlicht in: | Journal of voice 2024-12 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | Journal of voice |
container_volume | |
creator | Martínez-Cano, Alfonso de la Sacristana, Roberto Fernández-Baillo Gallego Martín-Conty, Jose Luis Mordillo-Mateos, Laura Bernal-Jimenéz, Juan José Polonio-López, Begoña Martínez-Lorca, Manuela |
description | Recent research on schizophrenia seeks to identify objective biomarkers of the disease. The voice, and in particular the fundamental frequency (F0), could be one of them.
We conducted a cross-sectional and descriptive study with a sample of 154 people. Of these, 46 were diagnosed with schizophrenia, 41 were at substance abuse, and 67 formed the control group, matched in variables of sex, age, and educational level, but without substance use compared with the high-risk group.
The biomechanical analyses of the voice indicated significant differences between the groups, differentiated by gender: in men (F = 5.316; P = 0.006) and in women (F = 4.13; P = 0.004). The greatest differences between groups were observed in the group of vulnerable individuals, with some stability of the F0 in people with schizophrenia. Furthermore, we found correlations between positive symptoms and decreased F0 (r = −0.353; P = 0.016).
Our study shows that schizophrenia is associated with decreased F0 in both men and women, and that medication could stabilize this decrease. These findings have important implications for the objective monitoring and diagnosis of schizophrenia. |
doi_str_mv | 10.1016/j.jvoice.2024.11.005 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3146948338</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0892199724003941</els_id><sourcerecordid>3146948338</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1566-818df04c54ac34770cc5c19ccd96585c9f11c548be464c42ab9b6c4da56d90113</originalsourceid><addsrcrecordid>eNp9kEFPGzEQha2qqITAP6iQj73s1rPrdewLEqWkRULiQMvVcsazitPNbrB3I8Gvr6NAjz3NYd6bN-9j7DOIEgSor5tysx8CUlmJSpYApRDNBzYDvagL2Wj9kc2ENlUBxixO2VlKGyFElbef2GltlBFCqxmzy6n3bkv96Dq-jPQ8UY8vfGj5uCb-dAjgoeePuA6vw24dqQ-Ou97zuzHxJ9dNxF3ijn8Lw9bFPxTfrd9DIpfonJ20rkt08Tbn7Pfy9tfNz-L-4cfdzfV9gdAoVWjQvhUSG-mwlouFQGwQDKI3qtENmhYgL_WKpJIoK7cyK4XSu0Z5IwDqOftyvLuLQ-6QRrsNCanrXE_DlGwNUhmp61pnqTxKMQ4pRWrtLob8_IsFYQ9o7cYe0doDWgtgM9psu3xLmFZb8v9M7yyz4OoooNxzHyjahCHTJB8i4Wj9EP6f8Bf7bItx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3146948338</pqid></control><display><type>article</type><title>Fundamental Frequency of the Voice in Schizophrenia and Its Value as a Biomarker of the Disease</title><source>Elsevier ScienceDirect Journals</source><creator>Martínez-Cano, Alfonso ; de la Sacristana, Roberto Fernández-Baillo Gallego ; Martín-Conty, Jose Luis ; Mordillo-Mateos, Laura ; Bernal-Jimenéz, Juan José ; Polonio-López, Begoña ; Martínez-Lorca, Manuela</creator><creatorcontrib>Martínez-Cano, Alfonso ; de la Sacristana, Roberto Fernández-Baillo Gallego ; Martín-Conty, Jose Luis ; Mordillo-Mateos, Laura ; Bernal-Jimenéz, Juan José ; Polonio-López, Begoña ; Martínez-Lorca, Manuela</creatorcontrib><description>Recent research on schizophrenia seeks to identify objective biomarkers of the disease. The voice, and in particular the fundamental frequency (F0), could be one of them.
We conducted a cross-sectional and descriptive study with a sample of 154 people. Of these, 46 were diagnosed with schizophrenia, 41 were at substance abuse, and 67 formed the control group, matched in variables of sex, age, and educational level, but without substance use compared with the high-risk group.
The biomechanical analyses of the voice indicated significant differences between the groups, differentiated by gender: in men (F = 5.316; P = 0.006) and in women (F = 4.13; P = 0.004). The greatest differences between groups were observed in the group of vulnerable individuals, with some stability of the F0 in people with schizophrenia. Furthermore, we found correlations between positive symptoms and decreased F0 (r = −0.353; P = 0.016).
Our study shows that schizophrenia is associated with decreased F0 in both men and women, and that medication could stabilize this decrease. These findings have important implications for the objective monitoring and diagnosis of schizophrenia.</description><identifier>ISSN: 0892-1997</identifier><identifier>ISSN: 1873-4588</identifier><identifier>EISSN: 1873-4588</identifier><identifier>DOI: 10.1016/j.jvoice.2024.11.005</identifier><identifier>PMID: 39690086</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Schizophrenia—Fundamental frequency—Biomarkers—Voice</subject><ispartof>Journal of voice, 2024-12</ispartof><rights>2024 The Voice Foundation</rights><rights>Copyright © 2024 The Voice Foundation. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1566-818df04c54ac34770cc5c19ccd96585c9f11c548be464c42ab9b6c4da56d90113</cites><orcidid>0009-0003-3897-6375</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jvoice.2024.11.005$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39690086$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martínez-Cano, Alfonso</creatorcontrib><creatorcontrib>de la Sacristana, Roberto Fernández-Baillo Gallego</creatorcontrib><creatorcontrib>Martín-Conty, Jose Luis</creatorcontrib><creatorcontrib>Mordillo-Mateos, Laura</creatorcontrib><creatorcontrib>Bernal-Jimenéz, Juan José</creatorcontrib><creatorcontrib>Polonio-López, Begoña</creatorcontrib><creatorcontrib>Martínez-Lorca, Manuela</creatorcontrib><title>Fundamental Frequency of the Voice in Schizophrenia and Its Value as a Biomarker of the Disease</title><title>Journal of voice</title><addtitle>J Voice</addtitle><description>Recent research on schizophrenia seeks to identify objective biomarkers of the disease. The voice, and in particular the fundamental frequency (F0), could be one of them.
We conducted a cross-sectional and descriptive study with a sample of 154 people. Of these, 46 were diagnosed with schizophrenia, 41 were at substance abuse, and 67 formed the control group, matched in variables of sex, age, and educational level, but without substance use compared with the high-risk group.
The biomechanical analyses of the voice indicated significant differences between the groups, differentiated by gender: in men (F = 5.316; P = 0.006) and in women (F = 4.13; P = 0.004). The greatest differences between groups were observed in the group of vulnerable individuals, with some stability of the F0 in people with schizophrenia. Furthermore, we found correlations between positive symptoms and decreased F0 (r = −0.353; P = 0.016).
Our study shows that schizophrenia is associated with decreased F0 in both men and women, and that medication could stabilize this decrease. These findings have important implications for the objective monitoring and diagnosis of schizophrenia.</description><subject>Schizophrenia—Fundamental frequency—Biomarkers—Voice</subject><issn>0892-1997</issn><issn>1873-4588</issn><issn>1873-4588</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kEFPGzEQha2qqITAP6iQj73s1rPrdewLEqWkRULiQMvVcsazitPNbrB3I8Gvr6NAjz3NYd6bN-9j7DOIEgSor5tysx8CUlmJSpYApRDNBzYDvagL2Wj9kc2ENlUBxixO2VlKGyFElbef2GltlBFCqxmzy6n3bkv96Dq-jPQ8UY8vfGj5uCb-dAjgoeePuA6vw24dqQ-Ou97zuzHxJ9dNxF3ijn8Lw9bFPxTfrd9DIpfonJ20rkt08Tbn7Pfy9tfNz-L-4cfdzfV9gdAoVWjQvhUSG-mwlouFQGwQDKI3qtENmhYgL_WKpJIoK7cyK4XSu0Z5IwDqOftyvLuLQ-6QRrsNCanrXE_DlGwNUhmp61pnqTxKMQ4pRWrtLob8_IsFYQ9o7cYe0doDWgtgM9psu3xLmFZb8v9M7yyz4OoooNxzHyjahCHTJB8i4Wj9EP6f8Bf7bItx</recordid><startdate>20241216</startdate><enddate>20241216</enddate><creator>Martínez-Cano, Alfonso</creator><creator>de la Sacristana, Roberto Fernández-Baillo Gallego</creator><creator>Martín-Conty, Jose Luis</creator><creator>Mordillo-Mateos, Laura</creator><creator>Bernal-Jimenéz, Juan José</creator><creator>Polonio-López, Begoña</creator><creator>Martínez-Lorca, Manuela</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0009-0003-3897-6375</orcidid></search><sort><creationdate>20241216</creationdate><title>Fundamental Frequency of the Voice in Schizophrenia and Its Value as a Biomarker of the Disease</title><author>Martínez-Cano, Alfonso ; de la Sacristana, Roberto Fernández-Baillo Gallego ; Martín-Conty, Jose Luis ; Mordillo-Mateos, Laura ; Bernal-Jimenéz, Juan José ; Polonio-López, Begoña ; Martínez-Lorca, Manuela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1566-818df04c54ac34770cc5c19ccd96585c9f11c548be464c42ab9b6c4da56d90113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Schizophrenia—Fundamental frequency—Biomarkers—Voice</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martínez-Cano, Alfonso</creatorcontrib><creatorcontrib>de la Sacristana, Roberto Fernández-Baillo Gallego</creatorcontrib><creatorcontrib>Martín-Conty, Jose Luis</creatorcontrib><creatorcontrib>Mordillo-Mateos, Laura</creatorcontrib><creatorcontrib>Bernal-Jimenéz, Juan José</creatorcontrib><creatorcontrib>Polonio-López, Begoña</creatorcontrib><creatorcontrib>Martínez-Lorca, Manuela</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of voice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martínez-Cano, Alfonso</au><au>de la Sacristana, Roberto Fernández-Baillo Gallego</au><au>Martín-Conty, Jose Luis</au><au>Mordillo-Mateos, Laura</au><au>Bernal-Jimenéz, Juan José</au><au>Polonio-López, Begoña</au><au>Martínez-Lorca, Manuela</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fundamental Frequency of the Voice in Schizophrenia and Its Value as a Biomarker of the Disease</atitle><jtitle>Journal of voice</jtitle><addtitle>J Voice</addtitle><date>2024-12-16</date><risdate>2024</risdate><issn>0892-1997</issn><issn>1873-4588</issn><eissn>1873-4588</eissn><abstract>Recent research on schizophrenia seeks to identify objective biomarkers of the disease. The voice, and in particular the fundamental frequency (F0), could be one of them.
We conducted a cross-sectional and descriptive study with a sample of 154 people. Of these, 46 were diagnosed with schizophrenia, 41 were at substance abuse, and 67 formed the control group, matched in variables of sex, age, and educational level, but without substance use compared with the high-risk group.
The biomechanical analyses of the voice indicated significant differences between the groups, differentiated by gender: in men (F = 5.316; P = 0.006) and in women (F = 4.13; P = 0.004). The greatest differences between groups were observed in the group of vulnerable individuals, with some stability of the F0 in people with schizophrenia. Furthermore, we found correlations between positive symptoms and decreased F0 (r = −0.353; P = 0.016).
Our study shows that schizophrenia is associated with decreased F0 in both men and women, and that medication could stabilize this decrease. These findings have important implications for the objective monitoring and diagnosis of schizophrenia.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>39690086</pmid><doi>10.1016/j.jvoice.2024.11.005</doi><orcidid>https://orcid.org/0009-0003-3897-6375</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0892-1997 |
ispartof | Journal of voice, 2024-12 |
issn | 0892-1997 1873-4588 1873-4588 |
language | eng |
recordid | cdi_proquest_miscellaneous_3146948338 |
source | Elsevier ScienceDirect Journals |
subjects | Schizophrenia—Fundamental frequency—Biomarkers—Voice |
title | Fundamental Frequency of the Voice in Schizophrenia and Its Value as a Biomarker of the Disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T08%3A56%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fundamental%20Frequency%20of%20the%20Voice%20in%20Schizophrenia%20and%20Its%20Value%20as%20a%20Biomarker%20of%20the%20Disease&rft.jtitle=Journal%20of%20voice&rft.au=Mart%C3%ADnez-Cano,%20Alfonso&rft.date=2024-12-16&rft.issn=0892-1997&rft.eissn=1873-4588&rft_id=info:doi/10.1016/j.jvoice.2024.11.005&rft_dat=%3Cproquest_cross%3E3146948338%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3146948338&rft_id=info:pmid/39690086&rft_els_id=S0892199724003941&rfr_iscdi=true |